IL6 and depressive disorder: The connection between treatment response and immunological biomarkers is supported by the correlation between interleukin (IL)-6 reduction and Hamilton Depression Rating Scale (HAM-D) score reduction [43], together with a tendency towards higher baseline macrophage migration inhibitory factor (MIF) levels in responders [44].